KFS:NYSEKingsway Financial Services, Inc. Analysis
Data as of 2026-05-19 - not real-time
$10.73
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Kingsway Financial Services posted a surprisingly strong first‑quarter, with revenue surging well beyond internal forecasts and both business segments showing momentum as the company heads into its seasonal peak.
However, the firm remains unprofitable, carries a heavy debt load relative to equity, and trades at an exceptionally high price‑to‑book multiple, suggesting that the market may be pricing in optimistic growth expectations. Technical indicators are mixed: the price is hovering close to a near‑term support zone, the MACD has turned bearish, and the RSI sits in a neutral range, while volume has been tapering. Investors should weigh the upside from the reported growth and acquisition plans against the underlying financial strain and elevated valuation.
However, the firm remains unprofitable, carries a heavy debt load relative to equity, and trades at an exceptionally high price‑to‑book multiple, suggesting that the market may be pricing in optimistic growth expectations. Technical indicators are mixed: the price is hovering close to a near‑term support zone, the MACD has turned bearish, and the RSI sits in a neutral range, while volume has been tapering. Investors should weigh the upside from the reported growth and acquisition plans against the underlying financial strain and elevated valuation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price near immediate support level
- bearish MACD crossover
- decreasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- strong revenue growth and double‑digit organic outlook
- planned acquisitions to broaden earnings base
- momentum in both core segments
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- persistent negative profitability and high leverage
- valuation still far above book and earnings
- exposure to cyclical consumer market and volatility
Key Metrics & Analysis
Financial Health
Revenue Growth38.50%
Profit Margin-6.73%
ROE-34.88%
ROA-1.58%
Debt/Equity239.94
P/B Ratio23.4
Op. Cash Flow$1.8M
Free Cash Flow$889.8K
Technical Analysis
TrendNeutral
RSI43.5
Support$10.15
Resistance$12.04
MA 20$11.16
MA 50$11.01
MA 200$12.91
MACDBearish
VolumeDecreasing
Fear & Greed Index89
Valuation
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.11
Volatility45.69%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.